Goldplat CEO Werner Klingenberg discusses dividend policy, share buybacks and the Kilimenpesa sale. Watch the full video here.
Well said Italian, a balanced view, not all this delving back years to finding completely obscure writings on the subject of ED. Liambooth, ALL you print is biased, i might be able to understand but unfortunately I wasn’t a fly on the wall, I would so loved to have been! Cannot imagine what went on and was said.
Anyway on another note, I was at my golf club yesterday and casually mentioned that I was invested in FUM with an ED product coming to market. Out of the other 7 guys sitting at the table, 6 had heard of the product with the conversation then lasting the next 20 minutes on the subject and I can tell you it was joyous for them.
This is going to spread like wild fire, if this product has any impact treating ED it’s going to be massive, plus I honestly don’t believe it will take much marketing, it will do it by itself!
Bucolic, This person has an agenda and the way they are going about it is ultimately making them look stupid. I understand that what they are doing, may have an impact on particularly new or not so knowledgeable investors, but as much as I dislike the way this person is posting I have to agree very much with Leveraged. Futura although small, have made some massive mistakes over the years, especially in my eyes wasting $8m on the phase 3 trial after the phase 2 had not been conducted properly. Ultimately with the results that were generated it may result in us share holders making big from it. But who knows, all is looking positive presently and I am feeling extremely positive and so looking forward to being updated with further RNS’s. Too call a fellow poster scum just because you and I do not agree with them is wrong! We do not know their ultimate reason behind the posts and we cannot guarantee the ultimate outcome of Med3000, but one thing I will say is the poster has a vendetta against the company and it’s possible success.
D, that is the same as what you have been writing all day long here, history, this product is new, if indeed the results were correct and it was having positive results with 60% of patients including severe that is quite remarkable! Just as Ralph says, I am sure these other products you mention do not have the same results.
You did not answer my question on Ken, he certainly comes over very positive in the sugar coated interviews on Proactive, but without being challenged on the subject. What is your opinions on what Ken says since Feb 20 until today?
There is one thing the company has got wrong, and Barder particularly, they simply avoid contact with shareholders, they do not issue all details freely. They definitely have got this wrong avoiding any questions/interrogation.
Look forward to your reply on Ken!
Liam booth or D, there seems to be an air of concern in this last post and the £30m spent by FUM May fade into insignificance if this gel is the real deal, you and your Merry men are certainly on a roll lately that’s for sure!
One question, not much mentioned about Ken, are you saying he is leading us down the garden path hand in hand with James?
Bucolic, Thanks for the reply, regarding the 20 black Africans, it is very apparent from Ken’s interview that the doctor/professor who is top in his field has taken great interest in this process even going to meet the FDA on one occasion. I am sure he will be well aware and selecting the correct candidates personally. Ken seemed to indicate this in his interview. The other 80 Eastern European’s I’m sure will have similar results as the 2019 trial.
Yes any issues can crop up, who knows, but as I said on Sunday this is now very much de-risked since European approval, it really does look to me that lessons have been learnt from past experiences. Now it’s all about partnerships and what is written in the detail of contracts. Futura have had hard lessons from partners sitting on products , that simply cannot happen this time, surely contracts will only be signed if previous bad experiences are dealt with in the contracts.
Ball in Futura’s court, bring it on. A game changing product!
Bucolic, good to see you are still holding, that says a lot. I am posting two interviews with Ken from end of 19 and beginning of 20. I feel that all aspects which are doubted are covered in these. Just as a matter of interest Bucolic, what are your reservations going forward that make you feel this has so much risk when you also consider where we stand today with the CE mark soon to be Issued.
The hard work is done, the share price reflects where Futura now stands since news broke, I have been sceptical about the quality of Med3000 , but with the CE mark now almost in place those doubts have faded. The outlook for an OTC product like this are truly undervalued in my eyes, I cannot believe there is going to be any male out there who is not going to want to have a dob of this gel to try out even if it’s not required.
There is one thing left now in order to propel the share price into many £s and that is the quality of partners signed up around the world and any clauses within the contracts signed in selling the product. Futura have the benefit of having had CSD (for what ever reason never making it, even although from what I read there were positive reviews plus TPR which still today sits dormant, nowhere to be seen.) Futura now have on board companies aiding them with negotiating the deals and with the knowledge and experience of past failures you’d like to believe there are no excuses in not signing EXACTLY the right deals. The ball lays very much in Futura’s court today, it is absolutely crucial that these deals are not rushed into and the intricate details of them is scrutinised before signing. As I said , they appear to have everything in place for this to happen and with previous experiences there can surely be no excuses this time.
The only thing that is going to restrain the share price going forward/rocketing with all the news coming through in months to come is if Lombard start selling. They made a pile leading up to results at end of 2019 by off loading. Now with around 20% , will they do the same again, let’s hope not.
idg, Exactly my stance on FUM, can only be going one way in the medium/long term. The question is by how much and I would suggest certainly multiples of where it stands now. An absolute no brainer, buy hold , has to literally be a case of printing money.
The journey is just beginning, nothing can stop this juggernaut now, it’s on the road and it’s rolling.
This is going to multiply from here on inwards, both throughout this year and beyond. There are no arguments against, FUM have succeeded!
Well I feel it is time to congratulate both the board and staff in their achievement in bringing Med 3000 to where it is today and all that is to come.
The directors have been slated at times throughout all the years I have been invested , the disappointment on 10/12/19 was the ultimate down point for me. Despite all setbacks, this small R&D company have come through delivering what I forecast to be such exciting times ahead.
From the Punchy Numbers quote, to the Proactive interview with Ken early in 2020 to announce Med 3000. These must have been testing times for the company in general.
Anyway I very much hope that it is JB who delivers the next Proactive interview, where he will once again use that celebrated phrase of Punchy Numbers, this time quoting new deals actually signed.
I always wondered if that would be JBs quote reminiscent of the infamous Gerald Ratner, the answer to that is now certainly NO as we move forward.
Surprised at the low share price and the many sells. Is this a case of history repeating itself when in 2019 Lombard continually sold millions of shares into the buying spree only to find failed results in December. Let’s face it Lombard hold in the region of 20% of the company with the rights to warrants at 40p if my memory is correct. They obviously have the ear of management unlike us small pi’s. Do watch for any RNS showing Lombard selling down. Don’t get suckered into buying more if it is them that are selling, many of us bought at inflated prices previously whilst they have been funding at the low price and selling stock way above what they paid for these.
Decided to buy in on the thought process we are in for a prolonged period of unstable markets. So many issues out there. I personally believe the markets are getting above themselves. Very happy with £1.26 share price but there seems little confidence around in TRIG at present but I’m sure this will change. In for the long term!